Skip to main content

Table 1 MTG patient demographics

From: Alzheimer’s disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway

 

AD patients

Controls

N

45

35

Gender (male/female)

22/23

17/18

Age of death

85.09 ± 6.24

84.46 ± 5.50

PMI

2.77 ± 0.69

2.87 ± 1.03

Plaque total

12.97 ± 2.25

4.65 ± 4.30

Tangle total

11.02 ± 4.16

3.96 ± 2.10

Braak Stage (range (median))

II – VI (V)

I – IV (III)

  1. Overview of patient characteristics in post-mortem middle temporal gyrus (MTG) brains used in this study. Data are presented in n or mean ± SD. Patients were age- and gender- matched and diagnosed with either Alzheimer’s disease (AD) or non-demented controls